What does cygnus — accumulated goodwill impairment mean?

Represents the total historical value of goodwill write-downs taken against the Cygnus segment since its acquisition. This cumulative figure provides insight into the long-term value destruction or historical overpayment associated with the segment's assets.

Maravai LifeSciences Holdings, Inc. (MRVI) Cygnus — Accumulated goodwill impairment

Screener

Other segment segments

TriLink

$209M+25.8%

Similar metrics at other companies

OPLNFinance — Accumulated goodwill impairment

$161.5M0.0%

OPLNMarketplace — Accumulated goodwill impairment

$250.8M0.0%

STAutomotive — Accumulated goodwill impairment

$0—

STIndustrials — Accumulated goodwill impairment

$394.3M+134%

IRMCORPORATE AND OTHER — Accumulated goodwill impairment

$26.01M0.0%

IRMGLOBAL RIM BUSINESS — Accumulated goodwill impairment

$132.41M0.0%

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

(2) The Cygnus segment had no accumulated goodwill impairment as of December 31, 2025 and 2024.

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s cygnus — accumulated goodwill impairment?: Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — accumulated goodwill impairment of $0 in Q4 2025.
What does cygnus — accumulated goodwill impairment mean?: Represents the total historical value of goodwill write-downs taken against the Cygnus segment since its acquisition. This cumulative figure provides insight into the long-term value destruction or historical overpayment associated with the segment's assets.